EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Plasma metabolomics for the preoperative diagnosis of parathyroid carcinoma

Jinheng Xiao iD, Ming Cui, Qingyuan Zheng, Sen Yang, Tianqi Chen, Ya Hu iD

Endocrine-Related Cancer · 2025

DOI: 10.1530/erc-24-0192 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrine-Related Cancer, 2025. Verfasst von Jinheng Xiao und 5 weiteren Autor:innen. Hauptthemen laut MEDLINE: Metabolomics, Parathyroid Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chinese Academy of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parathyroid carcinoma (PC) is a rare endocrine malignancy with a poor prognosis. Preoperative diagnosis remains a major challenge in clinical practice because of limited diagnostic methods and non-specific clinical features. This study aimed to describe the distinct plasma metabolic profiles of PC and parathyroid adenoma (PA) patients and identify promising biomarkers for the preoperative differential diagnosis of PC. A total of 115 patients were enrolled in this retrospective study, including 70 patients (24 PC and 46 PA) in the discovery cohort and 45 patients (15 PC and 30 PA) in the validation cohort. Plasma samples were collected before operation. LC–MS/MS analysis was utilised on the discovery cohort to explore the metabolic profile and find out differentially abundant metabolites. Subsequently, potential diagnostic biomarkers were verified in an external validation cohort to find out novel biomarkers for the differential diagnosis of PC before surgery. Compared with the plasma samples of PA patients, a total of three upregulated and 42 downregulated metabolites were identified by MS/MS in the plasma samples of PC patients. The differentially abundant metabolites were significantly enriched in the arachidonic acid, tryptophan, and hormone metabolism pathways. Notably, 7-ketodeoxycholic acid (P = 0.002, AUC = 0.804) and tryptophan (P < 0.001, AUC = 0.838) were confirmed to show high accuracy in differential diagnosis in the validation cohort. Therefore, metabolomics analysis of parathyroid neoplasms revealed significant differences in metabolic profiles between PAs and PCs. The plasma levels of 7-ketodeoxycholic acid and tryptophan could serve as potential diagnostic biomarkers for PC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetabolomicsParathyroid NeoplasmsHumansBiomarkers, TumorDiagnosis, DifferentialRetrospective StudiesTryptophanDeoxycholic AcidLiquid Chromatography-Mass SpectrometryMaleFemaleAdultMiddle AgedAged

Stichwörter der Autor:innen

7-ketodeoxycholic acidmetabolomicsparathyroid adenomaparathyroid carcinomatryptophan

Substanzen

Biomarkers, Tumor7-ketodeoxycholic acidTryptophanDeoxycholic Acid

Autor:innen und Institutionen

ORCID-Profile: Jinheng Xiao, Ya Hu

Förderung

  • Chinese Academy of Medical Sciences

Zitieren

APA

Xiao, J., Cui, M., Zheng, Q., Yang, S., Chen, T., & Hu, Y. (2025). Plasma metabolomics for the preoperative diagnosis of parathyroid carcinoma. Endocrine-Related Cancer. https://doi.org/10.1530/erc-24-0192

Vancouver

Xiao J, Cui M, Zheng Q, Yang S, Chen T, Hu Y. Plasma metabolomics for the preoperative diagnosis of parathyroid carcinoma. Endocrine-Related Cancer. 2025. doi:10.1530/erc-24-0192

BibTeX
@article{Xiao2025,
  author = {Xiao, Jinheng and Cui, Ming and Zheng, Qingyuan and Yang, Sen and Chen, Tianqi and Hu, Ya},
  title = {Plasma metabolomics for the preoperative diagnosis of parathyroid carcinoma},
  journal = {Endocrine-Related Cancer},
  year = {2025},
  doi = {10.1530/erc-24-0192}
}
Kostenlos starten →